1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 IVD Analyzers Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 IVD Analyzers Market, China
3.1 IVD Analyzers Market, China, Revenue ($m), 2018-2033
3.1.1 Clinical Chemistry Analyzers Market, China, Revenue ($m), by Segment, 2018-2033
3.1.2 Hematology Analyzers Market, China, Revenue ($m), by Segment, 2018-2033
3.1.3 Immunochemistry Analyzers Market, China, Revenue ($m), by Segment, 2018-2033
3.1.4 Next Generation Sequencers Market, China, Revenue ($m), by Segment, 2018-2033
3.1.5 Point of Care (POC) Analyzers Market, China, Revenue ($m), by Segment, 2018-2033
3.1.6 Polymerase Chain Reaction (PCR) Systems Market, China, Revenue ($m), by Segment, 2018-2033
3.2 IVD Analyzers Market, China, Volume (Units), 2018-2033
3.2.1 Clinical Chemistry Analyzers Market, China, Volume (Units), by Segment, 2018-2033
3.2.2 Hematology Analyzers Market, China, Volume (Units), by Segment, 2018-2033
3.2.3 Immunochemistry Analyzers Market, China, Volume (Units), by Segment, 2018-2033
3.2.4 Next Generation Sequencers Market, China, Volume (Units), by Segment, 2018-2033
3.2.5 Point of Care (POC) Analyzers Market, China, Volume (Units), by Segment, 2018-2033
3.2.6 Polymerase Chain Reaction (PCR) Systems Market, China, Volume (Units), by Segment, 2018-2033
3.3 IVD Analyzers Market, China, Average Price ($) , 2018-2033
3.4 IVD Analyzers Market, China, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in China, IVD Analyzers Market
4.1 F. Hoffmann-La Roche Ltd
4.1.1 Company Overview
4.2 Danaher Corp
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
4.4 Siemens Healthineers AG
4.4.1 Company Overview
4.5 Sysmex Corp
4.5.1 Company Overview
4.6 Bio-Rad Laboratories Inc
4.6.1 Company Overview
4.7 Thermo Fisher Scientific Inc
4.7.1 Company Overview
4.8 bioMerieux SA
4.8.1 Company Overview
4.9 Qiagen NV
4.9.1 Company Overview
4.10 Hologic Inc
4.10.1 Company Overview
5 IVD Analyzers Market Pipeline Products6 Financial Deals Landscape
6.1 Equity Offerings
6.1.1 IVD Medical to Raise Upto USD24.22 Million in Private Placement of Shares
6.2 Venture Financing
6.2.1 Beijing Liang Biotechnology (Liangping Bio, Hunan Liangping Biotechnology) Raises Funds through Angel Financing
7 Recent Developments
7.1 Corporate Communications
7.1.1 Nov 21, 2024: United Imaging Announces the First of Several New U.S. Product Launches For RSNA
7.1.2 Sep 10, 2024: Qlife is to Announce that Peter Warthoe will Return to the Management Group as Chief Scientific Officer
7.2 Legal And Regulatory
7.2.1 Oct 08, 2024: Microport Medbot Skywalker Orthopedic Surgical Robot Gets Approval in Japan
7.3 Other Significant Developments
7.3.1 Jan 07, 2025: Qlife Provides Update on Operational Progress in China
7.3.2 Sep 04, 2024: Production Of Egoo Consumables Now Established In China To Support On-going Clinical Trials And Future Sales
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: IVD Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033
Table 2: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033
Table 3: Hematology Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033
Table 4: Immunochemistry Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033
Table 5: Next Generation Sequencers Market, China, Revenue ($m), USD Constant, 2018-2033
Table 6: Point of Care (POC) Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033
Table 7: Polymerase Chain Reaction (PCR) Systems Market, China, Revenue ($m), USD Constant, 2018-2033
Table 8: IVD Analyzers Market, China, Volume (Units), 2018-2033
Table 9: Clinical Chemistry Analyzers Market, China, Volume (Units), 2018-2033
Table 10: Hematology Analyzers Market, China, Volume (Units), 2018-2033
Table 11: Immunochemistry Analyzers Market, China, Volume (Units), 2018-2033
Table 12: Next Generation Sequencers Market, China, Volume (Units), 2018-2033
Table 13: Point of Care (POC) Analyzers Market, China, Volume (Units), 2018-2033
Table 14: Polymerase Chain Reaction (PCR) Systems Market, China, Volume (Units), 2018-2033
Table 15: IVD Analyzers Market, China, Average Price ($), 2018-2033
Table 16: IVD Analyzers Market, China, Company Share by Revenue ($m), 2024
Table 17: IVD Analyzers Market Pipeline Products
Table 18: IVD Medical to Raise Upto USD24.22 Million in Private Placement of Shares
Table 19: Beijing Liang Biotechnology (Liangping Bio, Hunan Liangping Biotechnology) Raises Funds through Angel Financing
Table 20: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: IVD Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 2: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 3: Hematology Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 4: Immunochemistry Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 5: Next Generation Sequencers Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 6: Point of Care (POC) Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 7: Polymerase Chain Reaction (PCR) Systems Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 8: IVD Analyzers Market, China, Volume (Units), 2018-2033
Figure 9: Clinical Chemistry Analyzers Market, China, Volume (Units), 2018-2033
Figure 10: Hematology Analyzers Market, China, Volume (Units), 2018-2033
Figure 11: Immunochemistry Analyzers Market, China, Volume (Units), 2018-2033
Figure 12: Next Generation Sequencers Market, China, Volume (Units), 2018-2033
Figure 13: Point of Care (POC) Analyzers Market, China, Volume (Units), 2018-2033
Figure 14: Polymerase Chain Reaction (PCR) Systems Market, China, Volume (Units), 2018-2033
Figure 15: IVD Analyzers Market, China, Company Share (%), 2024